Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: Bi-annual CDTI Sponsor:   Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: bi-annual CDTI Sponsors:   Universiteit Antwerpen;   Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: Bi-annual CDTI Sponsor:   Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: bi-annual CDTI Sponsors:   Universiteit Antwerpen;   Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: Bi-annual CDTI Sponsor:   Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: bi-annual CDTI Sponsors:   Universiteit Antwerpen;   Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: Bi-annual CDTI Sponsor:   Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: bi-annual CDTI Sponsors:   Universiteit Antwerpen;   Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: Bi-annual CDTI Sponsor:   Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: bi-annual CDTI Sponsors:   Universiteit Antwerpen;   Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: Bi-annual CDTI Sponsor:   Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: bi-annual CDTI Sponsors:   Universiteit Antwerpen;   Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials